Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael John Kazley currently holds 22,668,516 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael John Kazley has been a net buyer of NBY stock. They have purchased $45.6M and sold $26.9K worth of shares.
Michael John Kazley's most recent insider trade was on Jun 15, 2026, when they sold 11,332,020 shares at $0.00 per share.
Michael John Kazley serves as Executive at NovaBay Pharmaceuticals, Inc. (NBY). They have executed 6 insider transactions totaling $45.7M over their tenure at the company.
Michael John Kazley holds the position of Executive at NovaBay Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Michael John Kazley has shown a buying trading pattern, with $45.6M in total purchases and $26.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael John Kazley was on Jan 16, 2026, when they purchased $45.6M worth of SDEV shares. This transaction involved 53,679,974 shares at $0.85 per share.
Michael John Kazley currently owns 22,668,516 shares of NovaBay Pharmaceuticals, Inc. (NBY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael John Kazley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael John Kazley has 6 Form 4 filings on record as an insider at NovaBay Pharmaceuticals, Inc..
Set alerts for Michael John Kazley and 40,000+ other insiders.